News
Explore how CRISPR could become a powerful antiviral tool against HIV, Hepatitis B, HPV, and more, based on emerging research.
STAT reporters chat about the mood in the gene editing field, M&A deals in biotech, and leadership changes at Novo Nordisk.
Currently, the researchers are using CRISPR-TO to move endogenous RNAs – RNA molecules that are naturally produced within the ...
New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.
Here’s how COVID-19 vaccine guidance is changing in the U.S. For people at high risk of severe COVID-19. The process of ...
Shares of CRISPR Therapeutics have struggled amid less-than-stellar sales of its Casgevy therapy. The company's gene-editing biotechnology holds much promise but still faces significant uncertainties.
deposition to the basement membrane in a 3D skin model, according to research published in Bioengineering & Translational Medicine. 1 The excision of exon 31 from RDEB keratinocytes and ...
Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals ... following delays caused by the COVID-19 pandemic. Additional participants were treated across three ...
This discount is shown at checkout, if applicable. CRISPR has come to COVID-19. The US Food and Drug Administration has granted Sherlock Biosciences an emergency use authorization (EUA ...
It’s been a monumental year for Crispr, the molecular tool scientists use to edit genetic material. This November, the United Kingdom authorized the first medical treatment using Crispr gene ...
Vertex Pharmaceuticals plans to sell a gene-editing treatment for sickle-cell disease. A patent on CRISPR could stand in the way. That’s a real nice CRISPR cure you have there. It would be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results